SOLIVERA CAPITAL

Thesis

Solivera Capital is an investment firm that partners with entrepreneurs to bring advanced technologies from validation to real-world execution. The firm's investment thesis centers on deep technology, with a particular focus on sectors where system execution is critical for outcomes. These include medical technologies moving into clinical use, systems that enhance communication and data transfer across constrained environments, and technologies that improve energy efficiency or reduce reliance on scarce resources. Solivera Capital invests globally, seeking innovative technologies, entrepreneurs, and overlooked markets. While specific fund sizes and AUM are not publicly disclosed, Solivera Capital's strategy appears to involve leading or co-leading investments in companies that are transitioning from technical development to market implementation. The firm's emphasis on "execution" suggests a preference for later-stage venture or growth-stage companies, though their specific stage preferences (pre-seed, seed, Series A-C, growth, buyout) are not detailed. The founding year and legal name of Solivera Capital are not explicitly stated in the provided search results. However, "SOLIVERA CAPITAL LIMITED" is registered in the UK, with its nature of business including "Activities of financial services holding companies" and "Fund management activities." The headquarters city/state/country for Solivera Capital is not definitively identified. A specific URL for pitch submissions or a general contact email address is not provided. The firm's website lists "Contact" as a section, suggesting a contact form or details are available there.